BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27906681)

  • 1. siRNA-mediated suppression of collagen type iv alpha 2 (COL4A2) mRNA inhibits triple-negative breast cancer cell proliferation and migration.
    JingSong H; Hong G; Yang J; Duo Z; Li F; WeiCai C; XueYing L; YouSheng M; YiWen O; Yue P; Zou C
    Oncotarget; 2017 Jan; 8(2):2585-2593. PubMed ID: 27906681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of siRNA-mediated down-regulation of CD147 on human breast cancer cells].
    Li Z; Li D; Li J; Huang P; Qin H
    Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):734-8. PubMed ID: 26702532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.
    Griffith J; Andrade D; Mehta M; Berry W; Benbrook DM; Aravindan N; Herman TS; Ramesh R; Munshi A
    Oncol Rep; 2017 Apr; 37(4):2382-2390. PubMed ID: 28260023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCSG1 siRNA delivered by lentiviral vector suppressed proliferation and migration of MDA-MB-231 cells.
    He JS; Xie N; Yang JB; Guan H; Chen WC; Zou C; Ouyang YW; Mao YS; Luo XY; Pan Y; Fu L
    Int J Mol Med; 2018 Mar; 41(3):1659-1664. PubMed ID: 29286089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
    Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
    BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells.
    Zhang P; Yang X; Yin Q; Yi J; Shen W; Zhao L; Zhu Z; Liu J
    PLoS One; 2016; 11(4):e0154471. PubMed ID: 27124117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of miRNA-135b on proliferation, invasion and migration of triple-negative breast cancer by targeting APC].
    Xin H; Jiang D; Lü Z; Sun S; Kong J; Li F
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2474-7. PubMed ID: 26711213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells.
    Hamurcu Z; Delibaşı N; Geçene S; Şener EF; Dönmez-Altuntaş H; Özkul Y; Canatan H; Ozpolat B
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):415-430. PubMed ID: 29288363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
    Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
    BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
    Wu T; Song H; Xie D; Zhao B; Xu H; Wu C; Hua K; Deng Y; Ji C; Hu J; Fang L
    Int J Oncol; 2018 Jun; 52(6):2001-2010. PubMed ID: 29568874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
    Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
    Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vector-mediated doxycycline-inducible USP39 shRNA or cDNA expression in triple-negative breast cancer cells.
    Liu S; Liu X; Wang H; Zhou Q; Liang Y; Sui A; Yao R; Zhao B; Sun M
    Oncol Rep; 2015 May; 33(5):2477-83. PubMed ID: 25812575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOTCH4 is a potential therapeutic target for triple-negative breast cancer.
    Nagamatsu I; Onishi H; Matsushita S; Kubo M; Kai M; Imaizumi A; Nakano K; Hattori M; Oda Y; Tanaka M; Katano M
    Anticancer Res; 2014 Jan; 34(1):69-80. PubMed ID: 24403446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA (LncRNA) RMST in triple-negative breast cancer (TNBC): Expression analysis and biological roles research.
    Wang L; Liu D; Wu X; Zeng Y; Li L; Hou Y; Li W; Liu Z
    J Cell Physiol; 2018 Oct; 233(10):6603-6612. PubMed ID: 29215701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells.
    Zhou Y; Lin S; Tseng KF; Han K; Wang Y; Gan ZH; Min DL; Hu HY
    BMC Cancer; 2016 Oct; 16(1):818. PubMed ID: 27769200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.